Kimberly-Clark's Q3 2025 results show premiumization, driving a seventh straight quarter of volume-plus-mix growth despite ...

Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...

One of the common rationales of any M&A deal is that the combined enterprise will generate a higher growth rate and perform ...

Kimberly-Clark (Nasdaq: KMB) is acquiring Kenvue (NYSE: KVUE), creating a health and wellness giant with $32 billion in revenue, and 10 brands generating over $1 billion in annual sales each (such as ...

On⁠ November 13, Argus analy⁠st John St‌aszak upgraded Kimberly-Clark Corporation (NASDAQ:KMB) to a Buy ratin‍g​ from Hold and set a $120 price targ‌et, according to a report by The Fly.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak ...

Kimberly-Clark Corporation KMB has experienced a steep decline over the past three months, with its shares tumbling 19.4%, underperforming the Zacks Consumer Products–Staples industry's dip of 9.9%.

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the household products stocks, including Kimberly-Clark ...

Kimberly-Clark (KMB) has quietly slipped over the past 3 months, even as its underlying business keeps growing revenue and ...

On December 1, Kimberly-Clark Corporation (NASDAQ:KMB)’s price target was reduced by BNP Paribas Exane to $110 from $127. The ...

Kimberly-Clark KMB (NYSE: KMB) recently reported its Q4 results, with revenues and earnings falling below the street estimates, and we believe KMB stock is fully valued, as discussed below. The ...

On October 31, 2014, Kimberly-Clark Corp. (NYSE: KMB; Market Capitalization: $41.5 billion) completed the tax-free spin-off of Halyard Health Inc. (NYSE: HYH; Market Capitalization: $1.8 billion).